Best cases from the AFIP: Malignant mesothelioma

Radiographics

Volumn 27, Issue 1, 2007, Pages 259-264

  Tyszko, Sean M ^a   Marano, Gary D ^a   Tallaksen, Robert J ^a   Gyure, Kymberly A ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; MESOTHELIOMA; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; THORAX RADIOGRAPHY; THORAX TUMOR;

HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; THORACIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847047265     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.271065105     Document Type: Article

References (16)

1. Miller BH, Rosado-de-Christenson ML, Mason AC, Fleming MV, White CC, Krasna MJ. Malignant pleural mesothelioma: radiologic-pathologic correlation. RadioGraphics 1996;16:613-644.
2. Selikoff IJ, Hammond EC, Seidman H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 1980;46:2736-2740.
3. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994;9:1781-1790.
4. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002;359:851-852.
5. Lee YC, Light RW, Musk AW. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med 2000;6:267-274.
6. Evans AL, Gleeson FV. Radiology in pleural disease: state of the art. Respirology 2004;9:300-312.
7. Wang ZJ, Reddy GP, Gotway MB, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. RadioGraphics 2004;24:105-119.
8. Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. J Thorac Imaging 2006;21(2):146-153.
9. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005;353:1591-1603.
10. Robinson BW, Creaney J, Lake RA, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003;362:1612-1616.
11. Singhal S, Wiewrodt R, Malden LD, et al. Gene expression profiling of malignant mesothelioma. Clin Cancer Res 2003;9:3080-3097.
12. Gordon GJ, Jensen RV, Hsiao LL, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 2002;62:4963-4967.
13. O'Byrne KJ, Edwards JG, Waller DA. Clinicopathological and biological prognostic factors in pleural malignant mesothelioma. Lung Cancer 2004;45(suppl 1):S45-S48.
14. Janne PA. Chemotherapy for malignant pleural mesothelioma. Clin Lung Cancer 2003;5:98-106.
15. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-2644.
16. Nowak AK, Byrne MJ, Williamson R, et al. A multicentre phase II study of cisplatin and gemcitabine in malignant mesothelioma. Br J Cancer 2002;87:491-496.